Naquila, Madelyn C.
HRN: 23 06 49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2023
FLUCONAZOLE 50MG (CAP)
05/29/2023
06/26/2023
PO
100mg
OD
Fungi Infection
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes